Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

Allen C Gao, Andrew J Armstrong, Andrew S Goldstein, Bing Li, Bryan A Smith, Daniel G Taylor, Donghui Cheng, Hailiang Hu, Hong Zhang, Jiaoti Huang, John K Lee, Jung Wook Park, Kefeng Lei, Lingfan Xu, Matthew B Rettig, Melissa Flowers, Owen N Witte, Qianben Wang, Qing Cheng, Qingfu Zhang, Qing Yang, Rachid Karam, PhD, Shannon J McCall, Sitao Wu, Suzette Farber-Katz, Tyler Landrith, Vickie Hsuan, William Butler, Xufeng Chen, Yan Chang, Yanjing Li, Yinglu Zhou, Yiping Shen